Evaluation of the Cost of a High-Dose Intravenous Iron Protocol in a Regional Hemodialysis Program: Research Letter

BACKGROUND: Intravenous (IV) iron and erythropoietin stimulating agents (ESAs) are standard treatments for anemia in patients receiving maintenance hemodialysis. These medications are associated with significant costs to hemodialysis programs and patients. Recent trial evidence demonstrated that a h...

Descripción completa

Detalles Bibliográficos
Autores principales: Papini, Adam, Manns, Braden J., Elliott, Meghan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Clinical Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851128/
https://www.ncbi.nlm.nih.gov/pubmed/35186304
http://dx.doi.org/10.1177/20543581211063984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851128/
https://www.ncbi.nlm.nih.gov/pubmed/35186304
http://dx.doi.org/10.1177/20543581211063984

Ejemplares similares